Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Cash from Financing Activities (2016 - 2025)

Bio-Techne has reported Cash from Financing Activities over the past 17 years, most recently at -$49.0 million for Q4 2025.

  • Quarterly results put Cash from Financing Activities at -$49.0 million for Q4 2025, up 41.57% from a year ago — trailing twelve months through Dec 2025 was -$251.7 million (down 21.05% YoY), and the annual figure for FY2025 was -$253.9 million, down 107.44%.
  • Cash from Financing Activities for Q4 2025 was -$49.0 million at Bio-Techne, down from -$44.2 million in the prior quarter.
  • Over the last five years, Cash from Financing Activities for TECH hit a ceiling of $150.8 million in Q1 2023 and a floor of -$90.5 million in Q2 2025.
  • Median Cash from Financing Activities over the past 5 years was -$52.9 million (2021), compared with a mean of -$31.4 million.
  • Biggest five-year swings in Cash from Financing Activities: skyrocketed 363.17% in 2021 and later tumbled 282.02% in 2025.
  • Bio-Techne's Cash from Financing Activities stood at -$53.4 million in 2021, then plummeted by 35.26% to -$72.2 million in 2022, then decreased by 12.75% to -$81.4 million in 2023, then decreased by 3.0% to -$83.8 million in 2024, then soared by 41.57% to -$49.0 million in 2025.
  • The last three reported values for Cash from Financing Activities were -$49.0 million (Q4 2025), -$44.2 million (Q3 2025), and -$90.5 million (Q2 2025) per Business Quant data.